Table 1.

Clinical and imaging characteristics of the 34 patients with neurosarcoidosis and the 78 control patients without neurosarcoidosis, but multiple sclerosis

	Neurosarcoidosis, n = 34	Multiple sclerosis, n = 78
Age, mean ± SD; y	52 ± 9.9	50 ± 11.3
M/F	16/18	24/54
Lesion volume T2, voxels; median (IQR)	2892 ± 8126*	15,305 ± 26,750*
Definite/Probable/Possible neurosarcoidosis; n	2/19/13
Multiple sclerosis type, RRMS/SPMS/PPMS; n		56/17/5
EDSS; median (IQR)	3 (1.6)	3 (3.4)
Disease duration, months; median (IQR)	24 (54)	120 (192)

y years, IQR interquartile range, SD standard deviation, M/F man/female ratio, RRMS relapsing remitting multiple sclerosis, SPMS secondary progressive multiple sclerosis, PPMS primary progressive multiple sclerosis, EDSS Expanded Disability Status Scale.

*Indicates significant difference using Mann–Whitney U test